In summary, CB significantly mitigates inflammatory damage in LPS-induced mastitis models by suppressing inflammatory cytokine production, inhibiting apoptosis, and downregulating ARPC3, ARPC4, and HSP70 expression. The gene discussed is ARPC4; the disease is mastitis.